Home
>
Antibodies
>
Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.

€0.00 (tax incl.)

Reference:

HY-P9903A

Brand:

Product Details

Product Details

Reference HY-P9903A

Data sheet

Size: Multiple sizes

Reactivity: PD-1/PD-L1

Application: Cancer-programmed cell death

CAS: 946414-94-4

Nivolumab (anti-PD-1)

€0.00 (tax incl.)

Anti-APC11

€0.00 (tax incl.)

Anti-GSK3 beta

€0.00 (tax incl.)

Please sign in first.

Sign in